Show simple item record

dc.contributor.authorParker, CC
dc.contributor.authorJames, ND
dc.contributor.authorBrawley, CD
dc.contributor.authorClarke, Noel W
dc.contributor.authorParmar, MKB
dc.date.accessioned2019-10-07T15:16:41Z
dc.date.available2019-10-07T15:16:41Z
dc.date.issued2019en
dc.identifier.citationParker CC, James ND, Brawley CD, Clarke NW, Parmar MKB. Radiotherapy for metastatic prostate cancer-authors' reply. Lancet. 2019 Sep 7;394(10201):830.en
dc.identifier.pmid31498099en
dc.identifier.doi10.1016/S0140-6736(19)31829-Xen
dc.identifier.urihttp://hdl.handle.net/10541/622193
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/S0140-6736(19)31829-Xen
dc.titleRadiotherapy for metastatic prostate cancer-authors' replyen
dc.typeArticleen
dc.contributor.departmentAcademic Urology Unit, Royal Marsden Hospital, London, SM2 5PT, UK.en
dc.identifier.journalLanceten
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record